Chargement en cours...
Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
Introduction: The SGLT-2 inhibitors (SGLT-2i) are a newer anti-diabetic drugs. Their use has tremendously increased due to their favorable profile but they are also the focus of attention because of their side effect of euglycemic diabetic ketoacidosis (euDKA), which is challenging to diagnose becau...
Enregistré dans:
| Publié dans: | J Endocr Soc |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090430/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.777 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|